发明公开
- 专利标题： CROSS SPECIES SINGLE DOMAIN ANTIBODIES TARGETING PD-L1 FOR TREATING SOLID TUMORS
-
申请号： EP22738126.6申请日： 2022-06-06
-
公开(公告)号： EP4352099A1公开(公告)日： 2024-04-17
- 发明人: ENGLISH, Hejiao , MERLINO, Glenn , HO, Mitchell , LI, Dan , DAY, Chi-Ping
- 申请人： The United States of America, as represented by The Secretary, Department of Health and Human Services
- 申请人地址： US Bethesda, MD 20892-7788 Office of Technology Transfer, National Institutes of Health, 6701 Rockledge Drive, Suite 700, MSC 7788,
- 专利权人： The United States of America, as represented by The Secretary, Department of Health and Human Services
- 当前专利权人： The United States of America, as represented by The Secretary, Department of Health and Human Services
- 当前专利权人地址： US Bethesda, MD 20892-7788 Office of Technology Transfer, National Institutes of Health, 6701 Rockledge Drive, Suite 700, MSC 7788,
- 代理机构： Mewburn Ellis LLP
- 优先权： US 202163208755 P 2021.06.09
- 国际申请： US2022032378 2022.06.06
- 国际公布： WO2022261017 2022.12.15
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61K35/17 ; A61P35/00 ; C12N5/22 ; C12N15/13 ; A61K47/68 ; G01N33/577
信息查询
